Haemonetics Corp. XNYS: HAE

Haemonetics Corp. Live Stock Price Today, Share Analysis and Chart

Name: Haemonetics Corp.: Is Infosys Ltd. worth buying?
Item: Haemonetics Corp.
Rating: 2.808861125
Author: Trendlyne DVM scores

Mid-range Performer

about

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company op...

75.08 -0.78 (-1.03%)

35.77% Gain from 52W Low

74,528

XNYS Volume

XNYS 31 Jul, 2025 11:38 AM (EDT)

Board Meeting

The next board meeting for Haemonetics Corp. is on 08 Aug 2025 for the purpose of Haemonetics Corp First Quarter Earnings Results for 2026 See details

High Financial Strength

61.1 / 100

Mid Valuation

45.7 / 100

Technically Neutral

56.8 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

1Yr Price target upside is 23%

11 analysts

Haemonetics Corp. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Haemonetics Corp. Live Stock Price Today, Share Analysis and Chart

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company op...

35.77% Gain from 52W Low

SWOT Analysis

Haemonetics Corp. Live Price Chart